Results for “honeywell-phd”

Recommends low-dose GH replacement in patients with cured acromegaly and documented GHD in the absence of known contraindications. Triggers include managing a cured acromegaly patient with documented growth hormone deficiency.

Generates a strategic NIH funding overview as an editable .docx file, including research positioning analysis, institute mapping, targeted grant discovery, and strategic recommendations for clinical researchers.

This skill identifies adult childhood cancer survivors with isolated growth hormone deficiency and prior hypothalamic‑pituitary axis radiation exposure who require retesting to confirm persistence of GHD. Triggers include clinician questions such as “Should I retest for GHD in this adult survivor with childhood GHD and radiation history?” or “Is repeat GHD evaluation indicated in this patient?”

This skill determines whether serum insulin-like growth factor-1 (IGF-I) levels alone can be used to diagnose growth hormone deficiency (GHD) in childhood cancer survivors exposed to hypothalamic-pituitary axis radiotherapy. Triggers include questions such as “Can I rely on IGF-I alone to diagnose GHD after cranial radiation?” or “Is IGF-I sufficient for GHD assessment post-HP RT?”